| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Alpha-1B adrenergic receptor |
|---|
| Ligand | BDBM30712 |
|---|
| Substrate/Competitor | n/a |
|---|
| Ki | 380±n/a nM |
|---|
| Comments | PDSP_1428 |
|---|
| Citation |  Horie, K; Hirasawa, A; Tsujimoto, G The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells. Eur J Pharmacol268:399-407 (1994) [PubMed] Article |
|---|
| More Info.: | Get all data from this article |
|---|
| |
| Alpha-1B adrenergic receptor |
|---|
| Name: | Alpha-1B adrenergic receptor |
|---|
| Synonyms: | ADA1B_MESAU | ADRA1B | Adrenergic receptor alpha | Alpha-1b adrenergic receptor | adrenergic Alpha1B |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 56514.13 |
|---|
| Organism: | C.H.O. |
|---|
| Description: | adrenergic Alpha1B ADRA1B C.H.O.::P18841 |
|---|
| Residue: | 515 |
|---|
| Sequence: | MNPDLDTGHNTSAPAQWGELKDANFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAI
VGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDI
WAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGP
LLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAG
VMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVV
GMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFM
RILGCQCRSGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGSQRTLP
SASPSPGYLGRGAQPPLELCAYPEWKSGALLSLPEPPGRRGRLDSGPLFTFKLLGEPESP
GTEGDASNGGCDATTDLANGQPGFKSNMPLAPGHF
|
|
|
|---|
| BDBM30712 |
|---|
| n/a |
|---|
| Name | BDBM30712 |
|---|
| Synonyms: | 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride | MLS000038040 | Oxymetazoline | SMR000059324 | cid_66259 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H24N2O |
|---|
| Mol. Mass. | 260.3746 |
|---|
| SMILES | Cc1cc(c(O)c(C)c1CC1=NCCN1)C(C)(C)C |t:11| |
|---|
| Structure | 
|
|---|
Search and Browse
